Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
Johnson & Johnson Continues to Build its Manufacturing Capacity and Partnerships to Meet Commitment and Global Need NEW BRUNSWICK, N.J., ...
Read moreDetails
